News
Spider-Man 4 will be a "fresh start" for Peter Parker, according to star Tom Holland, so forget everything you know about the character and get ready for a brand-new MCU adventure. The film, which ...
Incyte (NASDAQ:INCY) recently announced that it had achieved positive results from both of its phase 3 studies STOP-HS1 and STOP-HS2. Both of these late-stage studies were using the company's drug ...
Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis ...
Reports state the teens were wearing Spider-Man costumes. First News spoke to Sgt. Glenn Patton about some of the recent incidents at the business, as well as the surrounding community reporting ...
Wells Fargo analyst Derek Archila maintained a Hold rating on Incyte (INCY – Research Report) yesterday and set a price target of $58.00. The company’s shares closed yesterday at $62.01.
Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) fell 15.2% in the pre-market session after the company released phase three trial data for a skin condition treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results